Deutsche Bank’s SELLAS Life Sciences SLS Stock Holding History

Deutsche Bank’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81M	Buy	190,128 +52,482	+38%	+$362K	﹤0.01%	1716
2026 Q1	$582K	Buy	137,646 +45,958	+50%	+$206K	﹤0.01%	2497
2025 Q4	$346K	Sell	91,688 -29,337	-24%	-$57K	﹤0.01%	2761
2025 Q3	$195K	Buy	121,025 +118,690	+5,083%	+$211K	﹤0.01%	3074
2025 Q2	$5.11K	Buy	+2,335	New	+$3.58K	﹤0.01%	3523
2019 Q3	–	Sell	-14,597	Closed	-$82K	–	5233
2019 Q2	$82K	Buy	+14,597	New	+$518K	﹤0.01%	4305
2019 Q1	–	Hold	0	–	–	–	5408
2018 Q4	–	Hold	0	–	–	–	5394
2018 Q3	–	Sell	-6	Closed	-$414	–	5540
2018 Q2	$1K	Buy	+6	New	+$1.64K	﹤0.01%	5351
2018 Q1	–	Hold	0	–	–	–	5583
2017 Q4	–	Hold	0	–	–	–	5122
2017 Q3	–	Hold	0	–	–	–	5058
2017 Q2	–	Sell	-61	Closed	-$53.1K	–	5098
2017 Q1	$54K	Buy	61 +57	+1,425%	+$94.4K	﹤0.01%	4192
2016 Q4	$9K	Buy	+4	New	+$23.3K	﹤0.01%	4708

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Deutsche Bank's SLS Position: Q2 2026 in Review

Deutsche Bank increased its SELLAS Life Sciences (SLS) stake by 38% in Q2 2026, buying an estimated $362K and bringing the position to 190,128 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Deutsche Bank first reported a position in SLS in Q4 2016 and has held it in 9 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

Deutsche Bank held 190,128 shares of SELLAS Life Sciences worth $2.81M as of Q2 2026.
Deutsche Bank bought 52,482 SELLAS Life Sciences shares in Q2 2026, an estimated $362K.
SELLAS Life Sciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1716 holding.
Deutsche Bank first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 9 quarters since.
192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.